213 related articles for article (PubMed ID: 31710116)
1. Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin.
Deng M; Xue Y; Xu L; Wang Q; Wei J; Ke X; Wang J; Chen X
Cell Biochem Funct; 2020 Jan; 38(1):47-57. PubMed ID: 31710116
[TBL] [Abstract][Full Text] [Related]
2. Chrysophanol Suppresses Hypoxia-Induced Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Deng M; Xue YJ; Xu LR; Wang QW; Wei J; Ke XQ; Wang JC; Chen XD
Anat Rec (Hoboken); 2019 Sep; 302(9):1561-1570. PubMed ID: 30737895
[TBL] [Abstract][Full Text] [Related]
3. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
[TBL] [Abstract][Full Text] [Related]
4. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.
Li C; Cai G; Song D; Gao R; Teng P; Zhou L; Ji Q; Sui H; Cai J; Li Q; Wang Y
Biomater Sci; 2019 Aug; 7(9):3627-3639. PubMed ID: 31328737
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new cyathane diterpene that induces mitochondrial and autophagy-dependent apoptosis and shows a potent in vivo anti-colorectal cancer activity.
He L; Han J; Li B; Huang L; Ma K; Chen Q; Liu X; Bao L; Liu H
Eur J Med Chem; 2016 Mar; 111():183-92. PubMed ID: 26871659
[TBL] [Abstract][Full Text] [Related]
6. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Lu S; Obianom ON; Ai Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53.
Kamil M; Haque E; Mir SS; Irfan S; Hasan A; Sheikh S; Alam S; Ansari KM; Nazir A
Anticancer Agents Med Chem; 2019; 19(2):184-193. PubMed ID: 30370860
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
9. Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
Liu ZY; Tang ML; Ning JF; Hao YP; Zhou L; Sun X
Eur J Med Chem; 2020 May; 193():112194. PubMed ID: 32203786
[TBL] [Abstract][Full Text] [Related]
10. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
11. Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer.
Yang H; Wang X; Wang C; Yin F; Qu L; Shi C; Zhao J; Li S; Ji L; Peng W; Luo H; Cheng M; Kong L
Eur J Med Chem; 2021 Jan; 210():113080. PubMed ID: 33310286
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and apoptotic potential of gemini-chrysophanol nanoparticles against human colorectal cancer HCT-116 cell lines.
Naqishbandi AM
BMC Pharmacol Toxicol; 2022 Jul; 23(1):56. PubMed ID: 35870982
[TBL] [Abstract][Full Text] [Related]
13. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.
Hermanowicz JM; Szymanowska A; Sieklucka B; Czarnomysy R; Pawlak K; Bielawska A; Bielawski K; Kalafut J; Przybyszewska A; Surazynski A; Rivero-Muller A; Mojzych M; Pawlak D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):535-548. PubMed ID: 33522320
[TBL] [Abstract][Full Text] [Related]
14. Patrinia scabiosaefolia induces mitochondrial-dependent apoptosis in a mouse model of colorectal cancer.
Liu L; Shen A; Chen Y; Wei L; Lin J; Sferra TJ; Hong Z; Peng J
Oncol Rep; 2013 Aug; 30(2):897-903. PubMed ID: 23754194
[TBL] [Abstract][Full Text] [Related]
15. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
[TBL] [Abstract][Full Text] [Related]
16. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
17. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
[TBL] [Abstract][Full Text] [Related]
18. Chrysophanol Attenuates Manifestations of Immune Bowel Diseases by Regulation of Colorectal Cells and T Cells Activation In Vivo.
Lee HS; Jeong GS
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802855
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress triggered by Soyasapogenol B promotes apoptosis and autophagy in colorectal cancer.
Wang L; Yun L; Wang X; Sha L; Wang L; Sui Y; Zhang H
Life Sci; 2019 Feb; 218():16-24. PubMed ID: 30553871
[TBL] [Abstract][Full Text] [Related]
20. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
